Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of Systemic Sclerosis and Sjögren's Syndrome

Autoimmunity Reviews

Volumn 12, Issue 11, 2013, Pages 1046-1051

  Jimenez, Sergio A ^a   Piera Velazquez, Sonsoles ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Autoimmune diseases; Human specific genes; MicroRNAs; Non coding RNA; Sj gren's Syndrome; Systemic Sclerosis

Indexed keywords

CIRCULAR RIBONUCLEIC ACID; LONG UNTRANSLATED RNA; MICRORNA; PIWI INTERACTING RNA; RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AHI1 GENE; ASPM GENE; BREAST CANCER; FOXP2 GENE; GENE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; GENOME; HUMAN; LYMPHOCYTE; MICROCEPHALIN GENE; NONHUMAN; PATHOGENESIS; PROSTATE CANCER; RETINA MACULA DEGENERATION; REVIEW; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; HUMAN SPECIFIC GENES; MICRORNAS; NON-CODING RNA; SJÖGREN'S SYNDROME; SYSTEMIC SCLEROSIS;

ANIMALS; AUTOIMMUNE DISEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84881555160     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.04.004     Document Type: Review

References (105)

1. Chimpanzee Sequencing Analysis Consortium. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 2005, 437:69-87.
2. Clamp M., Fry B., Kamal M., et al. Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci U S A 2007, 4(104):19428-19433.
3. Amadio J.P., Walsh C.A. Brain evolution and uniqueness in the human genome. Cell 2006, 126:1033-1035.
4. Lambert N., Lambot M.A., Bilhau A., et al. Genes expressed in specific areas of the human fetal cerebral cortex display distinct patterns of evolution. PLoS One 2011, 6:e17753.
5. Konopka G., Bomar J.N., Winden K., et al. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature 2009, 462:213-217.
6. Bian S., Sun T. Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol 2011, 44:359-373.
7. Salta E., DeStrooper B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol 2012, 11:189-200.
8. Kouprina N., Pavlicek A., Mochida G.H., et al. Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion. PLoS Biol Mar 23 2004, 2:E126. [Epub].
9. Stahl P.D., Wainszelbaum M.J. Human-specific genes may offer a unique window into human cell signaling. Sci Signal 2009, 2:59.
10. Wainszelbaum M.J., Charron A.J., Kong C., et al. The hominoid-specific oncogene TBC1D3 activates Ras and modulates epidermal growth factor receptor signaling and trafficking. J Biol Chem 2008, 283:13233-13242.
11. Vandepoele K., Van Roy N., Staes K., et al. A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution. Mol Biol Evol 2005, 22:2265-2274.
12. Vandepoele K., Andries V., Van Roy N., et al. A constitutional translocation t(1;17) (p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS One 2008, 3:e2207.
13. Hornan D.M., Peirson S.N., Hardcastle A.J., et al. Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. Invest Ophthalmol Vis Sci 2007, 48:5388-5396.
14. Cooper D.N., Kehrer-Sawatzki H. Exploring the potential relevance of human-specific genes to complex disease. Hum Genomics 2011, 5:99-107.
15. Gu Y.S., Kong J., Cheema G.S., et al. The immunobiology of Systemic Sclerosis. Semin Arthritis Rheum 2008, 38:132-160.
16. Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and Systemic Sclerosis. Curr Opin Rheumatol 2008, 20:707-712.
17. Sakkas L.I., Chikanza I.C., Platsoucas C.D. Mechanisms of disease: the role of immune cells in the pathogenesis of Systemic Sclerosis. Nat Clin Pract Rheumatol 2006, 2:679-685.
18. Del Galdo F., Artlett C.M. T cells and B cells in the pathogenesis of Systemic Sclerosis: recent insights and therapeutic opportunities. Curr Rheumatol Rep 2006, 8:123-130.
19. Jonsson R., Vogelsang P., Volchenkov R., et al. The complexity of Sjögren's Syndrome: novel aspects on pathogenesis. Immunol Lett 2011, 141:1-9.
20. Peri Y., Agmon-Levin N., Theodor E., et al. Sjögren's Syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012, 1:105-117.
21. Ishikawa O., Ishikawa H. Macrophage infiltration in the skin of patients with Systemic Sclerosis. J Rheumatol Aug 1992, 19(8):1202-1206.
22. Kräling B.M., Maul G.G., Jimenez S.A. Mononuclear cellular infiltrates in clinically involved skin from patients with Systemic Sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 1995, 63(1):48-56.
23. Lafyatis R., York M. Innate immunity and inflammation in Systemic Sclerosis. Curr Opin Rheumatol 2009, 21:617-622.
24. York M.R. Novel insights on the role of the innate immune system in Systemic Sclerosis. Expert Rev Clin Immunol 2011, 7:481-489.
25. Bosello S., De Luca G., Tolusso B., et al. B cells in Systemic Sclerosis: a possible target for therapy. Autoimmun Rev 2011, 10:624-630.
26. Sakkas L.I., Xu B., Artlett C.M., et al. Oligoclonal T cell expansion in the skin of patients with Systemic Sclerosis. J Immunol 2002, 168:3649-3659.
27. Mehra S., Walker J., Patterson K., et al. Autoantibodies in Systemic Sclerosis. Autoimmun Rev 2013, 12:340-354.
28. Harris M.L., Rosen A. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 2003, 15:778-784.
29. Routsias J.G., Tzioufas A.G. Sjögren's Syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007, 32:238-251.
30. Tzioufas A.G., Tatouli I.P., Moutsopoulos H.M. Autoantibodies in Sjögren's Syndrome: clinical presentation and regulatory mechanisms. Presse Med 2012, 41:e451-e460.
31. Heeney J.L., Dalgleish A.G., Weiss R.A. Origins of HIV and the evolution of resistance to AIDS. Science 2006, 313:462-466.
32. Heeney J., Jonker R., Koomstra W., et al. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 1993, 22:194-200.
33. Walker C.M. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer Semin Immunopathol 1997, 19:85-98.
34. Bassett S.E., Brasky K.M., Lanford R.E. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998, 72:2589-2599.
35. Cohen J.I., Moskal T., Shapiro M., et al. Varicella in chimpanzees. J Med Virol 1996, 50:289-292.
36. Levine P.H., Leiseca S.A., Hewetson J.F., et al. Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus. Arch Virol 1980, 66:341-351.
37. Suntharalingam G., Perry M.R., Ward S., et al. Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006, 355:1018-1028.
38. St.Clair E.W. The calm after the cytokine storm: lessons from the TGN1412 trial. J Clin Invest 2008, 118:1344-1347.
39. Hünig T. The storm has cleared: lessons from the CD28 superagonist TGN1412 trial. Nat Rev Immunol 2012, 12:317-318.
40. Straud V., Kimberly R., Issacs J.D. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov 2007, 6:75-92.
41. Stebbings R., Findley L., Edwards C., et al. Cytokine storm in the Phase 1 trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007, 179:3325-3331.
42. + effector memory T-cells. Br J Pharmacol 2010, 161:512-526.
43. Soto P.C., Stein L.L., Hurtado-Ziola N., et al. Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol 2010, 184:4185-4195.
44. O'Bleness M., Searles V.B., Varki A., et al. Evolution of genetic and genomic features unique to the human lineage. Nat Rev Genet 2012, 13:853-866.
45. Gibcus J.H., Dekker J. The context of gene expression regulation. F1000 Biol Rep 2012, 4:8.
46. Barrett L.W., Fletcher S., Wilton S.D. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol Life Sci 2012, 69:3613-3634.
47. Khalil A.M., Guttman M., Huarte M., et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009, 106:11667-11672.
48. Guttman M., Amit I., Garber M., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
49. Mattick J.S., Makunin I.V. Non-coding RNA. Hum Mol Genet 2006, 15(Spec. No. 1):R17-R29.
50. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol Cell 2011, 16(43):904-914.
51. Wapinski O., Chang H.Y. Long noncoding RNAs and human disease. Trends Cell Biol 2011, 21:354-361.
52. Moran V.A., Perera R.J., Khalil A.M. Emerging function and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012, 1-10. 10.1093/nar/gks296.
53. Ambros V. The evolution of our thinking about microRNAs. Nat Med 2008, 14:1036-1040.
54. Janga S.C., Vallabhaneni S. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv Exp Med Biol 2011, 722:59-74.
55. Bushati N., Cohen S.M. MicroRNA functions. Annu Rev Cell Dev Biol 2007, 23:175-205.
56. Huang Y., Shen X.J., Zou Q., et al. Biological functions of microRNAs: a review. J Physiol Biochem 2011, 67:129-139.
57. Li L.C., Okino S.T., Zhao H., et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006, 10317337-10317342.
58. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008, l9:219-230.
59. Memczak S., Jens M., Elefsinioti A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature Feb 27 2013, 10.1038/nature11928.
60. Hansen T.B., Jensen T.I., Clausen B.H., et al. Natural RNA circles function as efficient microRNA sponges. Nature Feb 27 2013, 10.1038/nature11993.
61. Kosik K.S. Circles reshape the RNA world. Nature Feb 27 2013, 10.1038/nature11956.
62. Saj A., Lai E.C. Control of microRNA biogenesis and transcription by cell signaling pathways. Curr Opin Genet Dev 2011, 21:504-510.
63. Suzuki H.I., Miyazono K. Emerging complexity of microRNA generation cascades. J Biochem 2011, 149:15-25.
64. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
65. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
66. Cannell I.G., Kong Y.W., Bushell M. How do microRNAs regulate gene expression?. Biochem Soc Trans 2008, 1224-1231.
67. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
68. Djuranovic S., Nahvi A., Green R. A parsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
69. Rinn J.L., Kertesz M., Wang J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
70. Woo C.J., Kingston R.E. HOTAIR lifts noncoding RNAs to new levels. Cell 2007, 29:129. [1257-9].
71. Gupta R.A., Shah N., Wang K.C., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
72. Hu H.Y., Guo S., Xi J., et al. MicroRNA expression and regulation in human, chimpanzee, and macaque brains. PLoS Genet 2011, 7:e1002327.
73. Somel M., Liu X., Tang L., et al. MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol 2011, 9:e1001214.
74. Hu H.Y., He L., Fominykh K., et al. Evolution of the human-specific microRNA miR-941. Nat Commun 2012, 3:1145.
75. Beyer C., Distler J.H. Morphogen pathways in Systemic Sclerosis. Curr Rheumatol Rep 2013, 15:299.
76. Hsu E., Feghali-Bostwick C.A. Insulin-like growth factor-II is increased in Systemic Sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol 2008, 172:1580-1590.
77. McLean C.Y., Reno P.L., Pollen A.A., et al. Human-specific loss of regulatory DNA and the evolution of human-specific traits. Nature 2011, 10:216-219.
78. Fairbanks D.J., Fairbanks A.D., Ogden T.H., et al. NANOGP8: evolution of a human-specific retro-oncogene. G3 (Bethesda) 2012, 2:1447-1457.
79. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009, 32:189-194.
80. Leng R.X., Pan H.F., Qin W.Z., et al. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 2011, 22:141-147.
81. Alevizos I., Illei G.G. MicroRNAs in Sjögren's Syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010, 9:618-621.
82. Kapsogeorgou E.K., Gourzi V.C., Manoussakis M.N., et al. Cellular microRNAs (miRNAs) and Sjögren's Syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011, 37:129-135.
83. Ceribelli A., Nahid M.A., Satoh M., et al. MicroRNAs in rheumatoid arthritis. FEBS Lett 2011, 1:3667-3674.
84. Wittmann J., Jäck H.M. MicroRNAs in rheumatoid arthritis: midget RNAs with a giant impact. Ann Rheum Dis 2011, 70(Suppl. 1):i92-i96.
85. Chatzikyriakidou A., Voulgari P.V., Georgiou I., et al. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun Rev 2012, 11:636-641.
86. Thamilarasan M., Koczan D., Hecker M., et al. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev 2012, 11:174-179.
87. Junker A. Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS Lett 2011, 585:3738-3746.
88. Junker A., Hohlfeld R., Meinl E. The emerging role of microRNAs in multiple sclerosis. Nat Rev Neurol 2011, 7:56-59.
89. Iborra M., Bernuzzi F., Invernizzi P., et al. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 2012, 11:305-314.
90. Jiang X., Tsitsiou E., Herrick S.E., et al. MicroRNAs and the regulation of fibrosis. FEBS J 2010, 277:2015-2021.
91. Vettori S., Gay S., Distler O. Role of microRNAs in fibrosis. Open Rheumatol J 2012, 6:130-139.
92. Chau B.N., Xin C., Hartner J., et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 2012, 4(121):ra18.
93. Wang J., Huang W., Xu R., et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med Jan 19 2012.
94. Lakner A.M., Steuerwald N.M., Walling T.L., et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology Jan 25 2012.
95. Yang S., Banerjee S., de Freitas A., et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 2012, 180:484-493.
96. Pandit K.V., Milosevic J., Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 2011, 157:191-199.
97. Wei J., Battacharyya S., Tourtellotte Q.G., et al. Fibrosis in Systemic Sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 2011, 10:267-275.
98. Bhattachharyya S., Wei J., Varga J. Understanding fibrosis in Systemic Sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 2011, 8:42-54.
99. Zhu H., Li Y., Qu S., et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol Feb 4 2012.
100. Kawashita Y., Jinnin M., Makino T., et al. Circulating miR-29a levels in patients with scleroderma spectrum disorder. J Dermatol Sci 2011, 61:67-69.
101. Zavadil J., Narasimhan M., Blumenberg M., et al. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007, 185:157-161.
102. Korpal M., Lee E.S., Hu G., et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914.
103. Ghosh A.K., Nagpal V., Covington J.W., et al. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal 2012, 24:1031-1036.
104. Ikushima H., Miyazono K. TGF-ß signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-ß. Cell Tissue Res 2012, 347:37-49.
105. Kumarswamy R., Volkmann I., Jazbutyte V., et al. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arterioscler Thromb Vasc Biol 2012, 32:361-369.